Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity
Although expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which th...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/1984703 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832561104764534784 |
---|---|
author | Salome’ V. Ibba Mohamed A. Ghonim Kusma Pyakurel Matthew R. Lammi Anil Mishra A. Hamid Boulares |
author_facet | Salome’ V. Ibba Mohamed A. Ghonim Kusma Pyakurel Matthew R. Lammi Anil Mishra A. Hamid Boulares |
author_sort | Salome’ V. Ibba |
collection | DOAJ |
description | Although expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which the enzyme is adequately targeted. Here, we confirm iNOS expression in the asthmatic lung with concomitant protein nitration and poly(ADP-ribose) polymerase (PARP) activation. We show, for the first time, that iNOS is highly expressed in peripheral blood mononuclear cells (PBMCs) of asthmatics with uncontrolled disease, which did not correspond to protein nitration. Selective iNOS inhibition with L-NIL protected against AHR upon acute, but not chronic, exposure to ovalbumin or house dust mite (HDM) in mice. Supplementation of NO by nitrite administration significantly blocked AHR in chronically HDM-exposed mice that were treated with L-NIL. Protection against chronic HDM exposure-induced AHR by olaparib-mediated PARP inhibition may be associated with the partial but not the complete blockade of iNOS expression. Indeed, L-NIL administration prevented olaparib-mediated protection against AHR in chronically HDM-exposed mice. Our study suggests that the amount of iNOS and NO are critical determinants in the modulation of AHR by selective iNOS inhibitors and renews the potential of iNOS as a therapeutic target for asthma. |
format | Article |
id | doaj-art-989c7b6ab1eb435ca527f623bebc0b2e |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-989c7b6ab1eb435ca527f623bebc0b2e2025-02-03T01:25:56ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/19847031984703Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP ActivitySalome’ V. Ibba0Mohamed A. Ghonim1Kusma Pyakurel2Matthew R. Lammi3Anil Mishra4A. Hamid Boulares5The Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAPulmonary/Critical Care and Allergy/Immunology Section, School of Medicine, Louisiana State University, New Orleans, LA 70112, USAEosinophilic Disorder Center in the Section of Pulmonary Diseases, Tulane University School of Medicine, New Orleans, LA 70112, USAThe Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USAAlthough expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics. This dichotomy calls for better strategies with which the enzyme is adequately targeted. Here, we confirm iNOS expression in the asthmatic lung with concomitant protein nitration and poly(ADP-ribose) polymerase (PARP) activation. We show, for the first time, that iNOS is highly expressed in peripheral blood mononuclear cells (PBMCs) of asthmatics with uncontrolled disease, which did not correspond to protein nitration. Selective iNOS inhibition with L-NIL protected against AHR upon acute, but not chronic, exposure to ovalbumin or house dust mite (HDM) in mice. Supplementation of NO by nitrite administration significantly blocked AHR in chronically HDM-exposed mice that were treated with L-NIL. Protection against chronic HDM exposure-induced AHR by olaparib-mediated PARP inhibition may be associated with the partial but not the complete blockade of iNOS expression. Indeed, L-NIL administration prevented olaparib-mediated protection against AHR in chronically HDM-exposed mice. Our study suggests that the amount of iNOS and NO are critical determinants in the modulation of AHR by selective iNOS inhibitors and renews the potential of iNOS as a therapeutic target for asthma.http://dx.doi.org/10.1155/2016/1984703 |
spellingShingle | Salome’ V. Ibba Mohamed A. Ghonim Kusma Pyakurel Matthew R. Lammi Anil Mishra A. Hamid Boulares Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity Mediators of Inflammation |
title | Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity |
title_full | Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity |
title_fullStr | Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity |
title_full_unstemmed | Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity |
title_short | Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity |
title_sort | potential of inducible nitric oxide synthase as a therapeutic target for allergen induced airway hyperresponsiveness a critical connection to nitric oxide levels and parp activity |
url | http://dx.doi.org/10.1155/2016/1984703 |
work_keys_str_mv | AT salomevibba potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity AT mohamedaghonim potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity AT kusmapyakurel potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity AT matthewrlammi potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity AT anilmishra potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity AT ahamidboulares potentialofinduciblenitricoxidesynthaseasatherapeutictargetforallergeninducedairwayhyperresponsivenessacriticalconnectiontonitricoxidelevelsandparpactivity |